These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36185482)
1. Corrigendum: Diagnostic value of striatal Liu XL; Liu SY; Barret O; Tamagnan GD; Qiao HW; Song TB; Lu J; Chan P Front Aging Neurosci; 2022; 14():1029024. PubMed ID: 36185482 [TBL] [Abstract][Full Text] [Related]
2. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET. Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of striatal Liu XL; Liu SY; Barret O; Tamagnan GD; Qiao HW; Song TB; Lu J; Chan P Front Aging Neurosci; 2022; 14():931015. PubMed ID: 35936768 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461 [TBL] [Abstract][Full Text] [Related]
5. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [ Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386 [TBL] [Abstract][Full Text] [Related]
6. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687 [TBL] [Abstract][Full Text] [Related]
7. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [ Li J; Chen P; Bao Y; Sun Y; He J; Liu X Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482 [TBL] [Abstract][Full Text] [Related]
8. Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT. Jiang D; Kong Y; Ren S; Cai H; Zhang Z; Huang Z; Peng F; Hua F; Guan Y; Xie F Nucl Med Biol; 2020; 82-83():89-95. PubMed ID: 32120243 [TBL] [Abstract][Full Text] [Related]
9. PET Imaging of VMAT2 with the Novel Radioligand [ Nag S; Jahan M; Tóth M; Nakao R; Varrone A; Halldin C ACS Chem Neurosci; 2021 Dec; 12(24):4580-4586. PubMed ID: 34813272 [TBL] [Abstract][Full Text] [Related]
10. A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson's Disease Quantification. Pan Y; Liu S; Zeng Y; Ye C; Qiao H; Song T; Lv H; Chan P; Lu J; Ma T Front Aging Neurosci; 2022; 14():902169. PubMed ID: 35769601 [TBL] [Abstract][Full Text] [Related]
11. Deuterated Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111 [TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [ Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404 [TBL] [Abstract][Full Text] [Related]
14. Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [ Sun Y; Zhao N; Liu W; Liu M; Ju Z; Li J; Cheng Z; Liu X Mol Imaging Biol; 2018 Oct; 20(5):771-779. PubMed ID: 29520623 [TBL] [Abstract][Full Text] [Related]
15. Molar activity of [ Liu C; Tang J; Xu Y; Cao S; Fang Y; Zhao C; Chen Z J Pharm Biomed Anal; 2021 Sep; 203():114212. PubMed ID: 34153939 [TBL] [Abstract][Full Text] [Related]
16. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755 [TBL] [Abstract][Full Text] [Related]
18. 18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease. Yang Y; Cheon M; Kwak YT Dement Neurocogn Disord; 2017 Sep; 16(3):57-63. PubMed ID: 30906372 [TBL] [Abstract][Full Text] [Related]
19. [ Weng CC; Huang SL; Chen ZA; Lin KJ; Hsiao IT; Yen TC; Kung MP; Wey SP; Hsu CH Ann Nucl Med; 2017 Aug; 31(7):506-513. PubMed ID: 28451991 [TBL] [Abstract][Full Text] [Related]
20. Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using Kong Y; Zhou H; Feng H; Zhuang J; Wen T; Zhang C; Sun B; Wang J; Guan Y Front Neurosci; 2020; 14():682. PubMed ID: 32760240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]